CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 28 filers reported holding CATABASIS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $796,000 | +54.0% | 377,460 | +110.8% | 0.00% | 0.0% |
| Q1 2021 | $517,000 | -22.7% | 179,060 | +72.1% | 0.00% | 0.0% |
| Q2 2020 | $669,000 | +185.9% | 104,045 | +84.7% | 0.00% | – |
| Q1 2020 | $234,000 | -56.8% | 56,330 | -38.5% | 0.00% | – |
| Q4 2019 | $542,000 | +176.5% | 91,645 | +153.1% | 0.00% | – |
| Q3 2019 | $196,000 | -64.2% | 36,204 | -46.6% | 0.00% | – |
| Q2 2019 | $547,000 | -44.4% | 67,819 | -45.4% | 0.00% | -100.0% |
| Q1 2019 | $983,000 | +530.1% | 124,164 | +247.6% | 0.00% | – |
| Q4 2018 | $156,000 | – | 35,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eversept Partners, LP | 522,042 | $1,117,170 | 0.13% |
| XTX MARKETS LLC | 26,041 | $56,000 | 0.12% |
| Samsara BioCapital, LLC | 300,000 | $642,000 | 0.06% |
| Ikarian Capital, LLC | 650,000 | $1,392,000 | 0.06% |
| Opaleye Management Inc. | 187,750 | $402,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 108,026 | $231,000 | 0.04% |
| Anson Funds Management LP | 97,601 | $209,000 | 0.04% |
| Virtu Financial LLC | 83,221 | $178,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 47,084 | $101,000 | 0.02% |
| WEXFORD CAPITAL LP | 19,512 | $42,000 | 0.01% |